Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-14 Sale |
2021-10-18 7:02 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
359 | $81.14 | $29,129 | 38,416 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:58 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
303 | $81.14 | $24,585 | 25,030 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:55 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
358 | $81.14 | $29,048 | 40,148 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
140 | $81.14 | $11,360 | 14,072 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:48 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
286 | $81.14 | $23,206 | 216,266 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:46 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
310 | $81.14 | $25,153 | 28,358 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:41 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
358 | $81.14 | $29,048 | 49,764 (Direct) |
View |
| 2021-10-12 Sale |
2021-10-14 6:33 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
6,738 | $82 | $552,524 | 38,762 (Direct) |
View |
| 2021-09-08 Sale |
2021-09-09 6:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
7,336 | $100.65 | $738,368 | 46,332 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 6:11 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $100.11 | $500,525 | 147,275 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 5:11 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director |
800,000 | $54.54 | $43,631,250 | 1,400,000 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 11:56 am |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
375 | $91.53 | $34,324 | 25,333 (Direct) |
View |
| 2021-06-19 Sale |
2021-06-23 5:55 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
1,009 | $94.82 | $95,670 | 25,708 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 9:08 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
1,329 | $100 | $132,900 | 28,668 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:14 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
363 | $113.68 | $41,266 | 40,506 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:13 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
313 | $113.67 | $35,579 | 29,997 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:13 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
363 | $113.69 | $41,269 | 50,122 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:12 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
142 | $113.67 | $16,141 | 15,031 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:11 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
363 | $113.69 | $41,269 | 106,818 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:10 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
700 | $113.67 | $79,572 | 26,717 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:09 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
364 | $113.67 | $41,376 | 38,775 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 11:32 am |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
30,000 | $107.8 | $3,234,000 | 2,855,793 (Indirect Direct) |
View |
| 2021-04-20 Sale |
2021-04-21 8:07 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
396 | $104.28 | $41,295 | 27,417 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-19 5:17 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $109.09 | $545,450 | 97,139 (Direct) |
View |
| 2021-03-08 Sale |
2021-03-09 12:37 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
3,000 | $120.69 | $362,070 | 13,544 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:55 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
4,572 | $138.17 | $631,713 | 118,181 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:48 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
6,198 | $138.17 | $856,378 | 61,237 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-13 Gift |
2021-10-18 6:53 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
819 | $0 | 14,072 (Direct) |
View |
| 2021-10-14 Tax Withholding |
2021-10-18 6:44 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
853 | $81 | 2,854,088 (Direct) |
View |
| 2021-09-30 Exercise |
2021-10-01 12:57 pm |
N/A 2021-11-17 |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
109,734 | $0 | 216,552 (Direct) |
View |
| 2021-09-30 Exercise |
2021-10-01 12:57 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
109,734 | $0.31 | 216,552 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 6:22 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
7,336 | $54.5 | 46,332 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 6:22 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
7,336 | $0 | 46,332 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 6:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $55 | 147,275 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 6:11 pm |
N/A 2028-01-30 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $0 | 147,275 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 7:58 pm |
N/A 2031-06-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director |
11,150 | $0 | 11,150 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:27 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director |
6,270 | $0 | 18,570 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:26 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
6,270 | $0 | 151,780 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:25 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
6,270 | $0 | 16,695 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:24 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director |
6,270 | $0 | 18,570 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:24 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,270 | $0 | 19,820 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:23 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director |
6,270 | $0 | 18,570 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:22 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director |
6,270 | $0 | 11,820 (Direct) |
View |
| 2021-05-06 Tax Withholding |
2021-05-10 6:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
852 | $115.71 | 2,854,941 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 5:17 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $55 | 97,139 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 5:17 pm |
N/A 2028-01-30 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $0 | 97,139 (Direct) |
View |
| 2021-04-16 Option Award |
2021-04-19 5:16 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
1,500 | $0 | 15,044 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:55 pm |
N/A 2031-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
21,136 | $0 | 118,181 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:48 pm |
N/A 2031-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
21,136 | $0 | 61,237 (Direct) |
View |